Furthermore, treatment with DADS was found to induce the activation of phase II enzymes by protecting Nrf2 from proteasomal degradation of Keap1 and promoting Nrf2 nuclear accumulation, thereby inhibiting the occurrence of chemical-induced papilloma in mice [80]. This evidence concerns the gene NFE2L2 and papilloma.